--- canonical_name: Theacrine alternate_names: 1,3,7,9-Tetramethyluric Acid, TeaCrine, Tetramethyluric Acid, Temurin canonical_topic: Theacrine for Health & Longevity short_topic_lc: theacrine creation_date: 2026-0627-0141 creator_ai_fullname: Opus 4.8 --- # Theacrine for Health & Longevity

Evidence Review created on 06/27/2026 using [AI4L](https://github.com/forever-healthy/AI4L) / Opus 4.8 **Also known as:** 1,3,7,9-Tetramethyluric Acid, TeaCrine, Tetramethyluric Acid, Temurin ## Motivation Theacrine (also called 1,3,7,9-tetramethyluric acid) is a natural compound that closely resembles caffeine and is found in the leaves of a wild Chinese tea plant known as kucha. Like caffeine, it gently dampens the brain's "tired" signal, producing a sense of energy, focus, and improved mood. Unlike caffeine, early human data suggest the body does not build up tolerance to it as quickly, and it appears to raise blood pressure and heart rate less, which is why it has become popular as a smoother, longer-lasting energy ingredient in pre-workout and focus products. Interest in theacrine grew once a branded form became widely available in supplements and a small study reported that people felt more energetic and less fatigued without the usual jittery downsides. Animal work has also hinted at calming, anti-inflammatory, and liver-protective properties, raising the question of whether it offers anything beyond a caffeine substitute. This review examines what is currently known about theacrine: how it works, what benefits and risks the human and animal evidence support, how it is typically used, and where the science remains thin. The aim is to present the available evidence so that a reader can weigh it for themselves. **[Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol) - [Conclusion](#conclusion)** ## Recommended Reading This section lists high-quality, accessible resources that provide a broad overview of theacrine and its proposed effects. * [Theacrine From Camellia kucha and Its Health Beneficial Effects](https://pubmed.ncbi.nlm.nih.gov/33392238/) - Sheng et al., 2020 A narrative review summarizing the antioxidant, anti-inflammatory, locomotor, cognitive, and lipid-metabolism effects of theacrine, and a good entry point for understanding the breadth (and limits) of the current evidence. * [A Two-Part Approach to Examine the Effects of Theacrine (TeaCrine) Supplementation on Oxygen Consumption, Hemodynamic Responses, and Subjective Measures of Cognitive and Psychometric Parameters](https://pubmed.ncbi.nlm.nih.gov/27164220/) - Ziegenfuss et al., 2017 The most cited early human study, reporting that a single 200 mg dose increased self-reported energy and reduced fatigue without meaningful changes in blood pressure or heart rate. * [Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: involvement of adenosine and dopamine receptors](https://pubmed.ncbi.nlm.nih.gov/22579816/) - Feduccia et al., 2012 A foundational mechanistic study in rats showing theacrine activates both adenosine and dopamine systems and, notably, did not induce tolerance after repeated dosing — a key claim underlying its marketing. * [TeaCrine: A Detailed Guide To This Long-Lasting Theacrine Supplement For Energy And Focus](https://nootropicsdepot.com/articles/teacrine-the-supplement-alternative-to-caffeine/) - Nootropics Depot A practical, consumer-facing overview of theacrine's mechanisms, dosing, stacking with caffeine, and the rationale behind its "no-tolerance, no-crash" reputation. * [Theacrine: The Energizing Compound With a Boost — A Comprehensive Guide](https://drjustinlee.com/2024/09/19/theacrine-the-energizing-compound-with-a-boost-a-comprehensive-guide/) - Lee A clinician-authored guide that walks through theacrine's pharmacology, the caffeine comparison, and the current state of human evidence in accessible language. ## Grokipedia [Theacrine](https://grokipedia.com/page/Theacrine) - Grokipedia A broad reference entry covering theacrine's chemistry, natural sources, pharmacology, and the human and preclinical research base, useful as a structured starting overview. ## Examine [Theacrine](https://examine.com/supplements/theacrine/) - Examine Examine's independent, citation-backed summary of theacrine's claimed benefits, dosing, and safety, with an emphasis on grading the strength of the underlying evidence. ## ConsumerLab No dedicated ConsumerLab article or product test report for theacrine was found. ConsumerLab focuses its independent testing on widely sold vitamin, mineral, and herbal categories, and theacrine — a niche stimulant ingredient sold mostly within multi-ingredient pre-workout blends — does not currently have a standalone review. ## Systematic Reviews No systematic reviews or meta-analyses for theacrine were found on PubMed as of 27/06/2026. ## Mechanism of Action Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid — a small plant-derived molecule built on the same chemical skeleton as caffeine. Its effects appear to arise from several overlapping actions. * **Adenosine receptor blockade:** Adenosine is a molecule that accumulates during waking hours and promotes drowsiness by acting on adenosine receptors (docking sites that slow nerve activity). Like caffeine, theacrine blocks these receptors (particularly the A1 and A2A subtypes), reducing the sensation of fatigue and increasing alertness. Animal work shows theacrine counteracts adenosine-induced sedation and reverses caffeine-induced insomnia, confirming it engages this system. * **Dopaminergic signaling:** Dopamine is a neurotransmitter (chemical messenger) central to motivation and reward. Rodent studies show theacrine's stimulant-like, movement-increasing effect is partly blocked by dopamine receptor blockers, indicating it also enhances dopamine signaling — a likely basis for its reported mood and motivation effects. * **Anti-inflammatory and antioxidant activity:** In animal and cell models, theacrine reduces inflammatory signaling and oxidative stress, in part by activating SIRT3 (a protein that supports mitochondrial health, the cell's energy factories) and the Nrf2 pathway (a master switch that turns on the body's own antioxidant defenses). A central and somewhat paradoxical point is that the same molecule shows both stimulant and sedative-like effects depending on dose and context. At lower doses and in alert states it acts as a mild stimulant; at higher doses in some animal models it prolongs sleep. The leading explanation is that theacrine modulates rather than simply blocks the adenosine system, but this dual behavior is not fully resolved, and competing interpretations — direct receptor effects versus downstream changes in adenosine availability — both remain on the table. Regarding pharmacological properties: theacrine is orally absorbed with a long elimination half-life of roughly 16–22 hours in humans, considerably longer than caffeine's ~5 hours, which underlies its "long-lasting" reputation. Human pharmacokinetic work shows that co-ingesting caffeine increases theacrine's peak concentration and total exposure (likely by enhancing its absorption) without changing its half-life, while theacrine does not alter caffeine's pharmacokinetics. Detailed human data on tissue distribution and the specific metabolizing enzymes remain limited. ## Historical Context & Evolution * **Original context:** Theacrine was first characterized as a natural constituent of kucha (*Camellia assamica* var. *kucha*, also classified as *Camellia kucha*), a wild bitter tea traditionally consumed in parts of southern China. In this setting it was never an isolated "intervention" but simply one of several alkaloids in a traditional beverage valued for its stimulating and reputedly calming qualities. Early 21st-century phytochemistry work established how the plant biosynthesizes theacrine from caffeine. * **Why it came to be considered for health optimization:** Interest shifted from botany to supplementation in the 2010s, when a branded, nature-identical form (TeaCrine) was developed and marketed as a caffeine alternative. The appeal rested on three claims drawn from early research: a longer duration of action, less tolerance build-up with repeated use, and a gentler cardiovascular profile than caffeine. A 2016 eight-week human safety study and a 2017 acute-effects study provided the initial scientific footing for these claims. A relevant conflict of interest applies here: a large share of the early supportive human evidence was funded or conducted by parties with a direct commercial stake in theacrine's adoption — the ingredient supplier Compound Solutions (which markets the branded TeaCrine form), Supplement Formulators, and industry-affiliated contract research groups such as the Center for Applied Health Sciences — so these favorable early findings should be read with that financial interest in mind. * **Evolution of opinion:** The early framing of theacrine as a clearly superior, "non-habituating" caffeine substitute has been tempered by later research. Several controlled exercise-performance trials found no ergogenic benefit, and a 2024–2026 wave of dose-response studies produced mixed results — some cognitive benefits at higher doses, but also signals of raised blood pressure and cortisol and reported side effects at the highest doses tested. The current picture is less a settled consensus and more an open question: the smoother subjective profile is reasonably supported, but objective performance and long-term longevity benefits remain unproven, and newer high-dose data invite caution rather than confirming the original optimistic narrative. ## Expected Benefits A dedicated search across human trials, mechanistic studies, and expert summaries was performed to assemble the benefit profile below. Most human evidence concerns acute energy, mood, and cognition; broader longevity-relevant effects rest largely on animal and cell data. ### Medium 🟩 🟩 #### Increased Subjective Energy and Reduced Fatigue Across several human studies, single doses of roughly 200 mg of theacrine (often as TeaCrine) increased self-reported energy, alertness, and motivation while reducing feelings of fatigue, with effects appearing within 1–2 hours and persisting for hours given the compound's long half-life. The proposed mechanism is adenosine receptor blockade combined with enhanced dopamine signaling. Evidence comes from small randomized, placebo-controlled crossover trials; the consistency of the subjective signal is the main strength, while reliance on self-report and small samples is the main limitation. **Magnitude:** Improvements in subjective energy and fatigue scales of roughly 10–30% versus placebo at ~200 mg in small trials; effects are perceptual rather than objectively measured. #### Improved Mood and Concentration Human studies and a human pharmacokinetic-pharmacodynamic report describe improvements in mood, concentration, and "willingness to exercise" after theacrine, particularly when combined with caffeine. The mechanism is thought to involve dopaminergic activation alongside adenosine blockade. The evidence base is small randomized trials plus combination-product studies, so isolating theacrine's independent contribution from caffeine is difficult. **Magnitude:** Modest, self-reported improvements in mood and concentration versus placebo in small trials; not consistently quantified with objective cognitive endpoints. ### Low 🟩 #### Cognitive Performance Under Fatigue (with Caffeine) In randomized trials of tactical/military personnel, combinations of lower-dose caffeine plus theacrine (and sometimes methylliberine) improved reaction time, vigilance, and accuracy on demanding cognitive tasks — in some measures matching or exceeding double the dose of caffeine alone, with fewer blood-pressure increases. A dose-response sleep study also found 400 mg improved some next-morning vigilance measures. The evidence is limited because benefits are largely shown in combination with caffeine, and theacrine-alone cognitive effects are inconsistent. **Magnitude:** Faster reaction times and reduced lapses versus placebo in combination products; theacrine-alone cognitive benefits are small and inconsistent across tasks. #### Smoother Stimulation than Caffeine (Lower Hemodynamic Impact) At commonly used doses (~200 mg), theacrine appears to raise heart rate and blood pressure less than equivalent stimulation from caffeine, and a human drug-interaction study found no significant hemodynamic changes when theacrine and caffeine were combined. This is attributed to its distinct receptor activity and slower kinetics. The benefit is real at moderate doses but conditional — higher doses (≥6 mg/kg) have raised blood pressure in more recent trials. **Magnitude:** Negligible change in heart rate and blood pressure at ~200 mg in several trials, versus measurable increases typical of comparable caffeine doses. ### Speculative 🟨 #### Liver Protection and Improved Lipid Metabolism In rodent models, theacrine reduced restraint-stress-induced liver damage, improved markers of non-alcoholic fatty liver disease by influencing fat (acylcarnitine) metabolism, and attenuated liver fibrosis via the SIRT3 pathway. No controlled human studies have tested these effects, so the basis is mechanistic and animal-only. #### Anti-Inflammatory and Analgesic Effects Theacrine showed dose-dependent anti-inflammatory and pain-relieving effects in classic rodent models — in some cases where caffeine did not — and reduced inflammatory signaling in cell systems. Human confirmation is absent, so this remains a mechanistic and animal-derived possibility rather than an established benefit. #### Neuroprotection and Antidepressant-Like Effects Animal studies report that theacrine promotes new neuron growth in the hippocampus, reduces depression-like behavior under chronic stress, and protects neurons in models of Parkinson's disease and stroke, largely through SIRT3 and antioxidant pathways. These findings are intriguing for longevity and brain health but are entirely preclinical. #### Sleep and Sedative-Like Effects at Specific Doses Some animal work shows theacrine can prolong sleep and act in a sedative-like manner via the adenosine system, and human dose-response data found high doses did not significantly disrupt subsequent sleep. Whether this translates into a meaningful sleep benefit in humans is unknown and rests on indirect evidence. ## Benefit-Modifying Factors * **Habitual caffeine intake:** Regular caffeine consumers may experience blunted subjective effects, as both compounds act on the adenosine system; conversely, co-ingesting caffeine increases theacrine's absorption and may enhance its perceived benefit. * **Baseline fatigue and sleep state:** The most consistent benefits — energy, mood, vigilance — appear in fatigued or sleep-restricted states, suggesting people starting from a rested baseline may notice less. * **Sex-based differences:** Human theacrine trials have included both men and women but are generally too small to detect sex-specific differences in response; no reliable sex-based effect on benefits has been established. * **Body mass and dosing:** Because some studies dose by body weight (mg/kg), larger individuals on fixed-dose products may receive a relatively lower effective dose, potentially reducing benefit. * **Pre-existing health conditions:** Individuals with conditions affecting dopamine or adenosine signaling, or those on stimulant-sensitive cardiovascular conditions, may respond differently, though direct data are lacking. * **Age-related considerations:** Nearly all human data come from healthy young adults; whether middle-aged or older adults at the upper end of the target range derive the same energy and cognitive benefits is untested. ## Potential Risks & Side Effects A dedicated search of human trials, supplement safety studies, and drug-reference summaries was performed to compile the risk profile. Theacrine has a relatively clean short-term safety record at moderate doses, but higher-dose data are less reassuring. ### Low 🟥 #### Elevated Blood Pressure at Higher Doses While ~200 mg doses generally do not meaningfully change blood pressure, a 2025 randomized trial found that 6 mg/kg theacrine increased resting systolic and diastolic blood pressure, and combination-product studies have shown modest systolic increases. The mechanism is its stimulant-like adenosine and dopamine activity. The risk is dose-dependent and most relevant to those exceeding typical supplement doses or with pre-existing hypertension. **Magnitude:** Measurable resting blood-pressure increases at 6 mg/kg (≈400–500 mg for many adults); minimal change at ~200 mg. #### Stimulant-Type Side Effects at Higher Doses A 4 km cycling trial reported that 3 and 6 mg/kg doses provoked gastrointestinal discomfort, perceived rapid heartbeat, dizziness, headache, head pressure, hand tremor, and low motivation in some participants. These are typical stimulant effects, more likely at higher doses and in stimulant-sensitive or caffeine-naïve individuals. **Magnitude:** Reported in a subset of participants at 3–6 mg/kg; frequency and severity not precisely quantified, but sufficient that the authors questioned its use as a supplement. #### Increased Cortisol at High Doses A 2026 crossover study testing 3, 6, and 9 mg/kg found that theacrine raised salivary cortisol (a stress hormone) versus placebo at 2 and 3 hours post-dose, without improving subjective energy. The significance of a transient cortisol rise is uncertain, but it counters the assumption that theacrine is purely benign at high doses. **Magnitude:** Statistically higher salivary cortisol at high doses (up to 9 mg/kg) versus placebo; clinical relevance unclear. ### Speculative 🟨 #### Long-Term and Chronic-Use Safety The longest controlled human safety study followed 8 weeks of up to 300 mg daily and found no adverse changes in blood markers, organ-function tests, or heart rhythm. Beyond 8 weeks, there are no human data, so risks of prolonged daily use — particularly relevant for a longevity-oriented user taking it continuously — are unknown and inferred from short-term data only. #### Interactions with Caffeine and Other Stimulants Because caffeine increases theacrine exposure and the two are almost always combined in products, real-world stimulant load may be higher than the label suggests. Additive stimulant effects (anxiety, palpitations, raised blood pressure) are plausible but have not been systematically studied at higher combined doses. #### Pregnancy, Breastfeeding, and Vulnerable Populations No human safety data exist for theacrine in pregnancy, breastfeeding, children, or people with significant cardiovascular, liver, or psychiatric disease. The absence of evidence — not evidence of safety — is the basis for caution in these groups. ## Risk-Modifying Factors * **Genetic polymorphisms:** No theacrine-specific pharmacogenetic data exist; however, individuals with variants affecting stimulant sensitivity or catecholamine breakdown (e.g., COMT, the enzyme that clears dopamine and related signaling molecules) might theoretically experience stronger stimulant-type effects. * **Baseline blood pressure:** Those with elevated or poorly controlled blood pressure are more likely to experience meaningful increases, especially at higher doses or when stacked with caffeine. * **Sex-based differences:** Current trials are underpowered to detect sex differences in side effects; no reliable difference has been demonstrated. * **Pre-existing cardiovascular or psychiatric conditions:** People with arrhythmias, anxiety disorders, or hypertension may be more susceptible to stimulant-type adverse effects and have been largely excluded from existing trials. * **Age-related considerations:** Older adults, who may have higher baseline blood pressure and altered drug clearance, are essentially unstudied; the cleaner safety profile seen in healthy young adults should not be assumed to extend to them. * **Habitual stimulant load:** People already consuming high daily caffeine may reach an additive stimulant threshold sooner, increasing the chance of jitteriness, palpitations, or sleep disruption. ## Key Interactions & Contraindications * **Caffeine (stimulants):** Caffeine increases theacrine's blood concentration and exposure, and the two are commonly combined. **Severity:** caution. **Consequence:** amplified stimulant effects and potentially higher theacrine levels than expected; consider lower combined doses and avoid late-day use. * **Other CNS stimulants (prescription):** Combining theacrine with prescription stimulants such as amphetamine-based ADHD (attention-deficit/hyperactivity disorder) medications that act on the central nervous system (CNS, the brain and spinal cord) — for example amphetamine/dextroamphetamine, methylphenidate — or decongestants (e.g., pseudoephedrine) is theoretically additive. **Severity:** caution. **Consequence:** increased heart rate, blood pressure, anxiety; separate use or avoid stacking. * **Antihypertensive medications:** Because higher doses can raise blood pressure, theacrine may blunt the effect of blood-pressure-lowering drugs (e.g., ACE inhibitors such as lisinopril, calcium channel blockers such as amlodipine). **Severity:** monitor. **Consequence:** reduced blood-pressure control; monitor if combined. * **Over-the-counter stimulant/energy products:** OTC caffeine pills, energy drinks, and "fat-burner" blends compound the stimulant load. **Severity:** caution. **Consequence:** additive cardiovascular and anxiety effects. * **Supplement interactions (additive stimulants):** Supplements with stimulant or stress-axis effects — caffeine-containing pre-workouts, synephrine (bitter orange), yohimbine, methylliberine (Dynamine), and high-dose green tea extract — can add to theacrine's stimulant and cortisol effects. **Severity:** caution. **Consequence:** jitteriness, palpitations, raised blood pressure. * **MAO inhibitors and serotonergic/dopaminergic agents:** Given dopaminergic activity, theoretical caution applies with MAO inhibitors (a class of older antidepressants). **Severity:** caution (theoretical). **Consequence:** unpredictable stimulant or mood effects. * **Populations who should avoid or use caution:** Pregnant or breastfeeding women; children and adolescents; people with uncontrolled hypertension; those with cardiac arrhythmias or recent cardiovascular events; people with anxiety disorders or insomnia; and those with significant liver disease — all should avoid theacrine or use it only under medical supervision given the absence of safety data in these groups. ## Risk Mitigation Strategies * **Start low and assess tolerance:** Begin at 50–100 mg to gauge individual sensitivity before moving toward the commonly studied ~200 mg dose, mitigating stimulant-type side effects (jitteriness, headache, palpitations) seen mainly at higher doses. * **Cap the daily dose at moderate levels:** Keeping intake at or below ~200–300 mg per day stays within the range where blood-pressure, cortisol, and side-effect signals are minimal, avoiding the adverse effects reported at 6–9 mg/kg. * **Avoid weight-based high dosing:** Because side effects and blood-pressure increases cluster at 3–6 mg/kg and above, prefer fixed moderate doses over aggressive mg/kg dosing to prevent hemodynamic and stimulant adverse effects. * **Account for stacked caffeine:** Since caffeine raises theacrine exposure, reduce total caffeine intake when combining the two and prefer products with lower caffeine, mitigating additive stimulant load, anxiety, and blood-pressure effects. * **Dose earlier in the day:** Given the long 16–22 hour half-life, taking theacrine in the morning or early afternoon reduces the risk of sleep disruption from residual stimulation. * **Monitor blood pressure if at risk:** People with elevated baseline blood pressure who choose to use theacrine should check blood pressure periodically (e.g., before starting and after 1–2 weeks) to detect meaningful increases, addressing the dose-dependent hypertension risk. * **Limit continuous use pending long-term data:** Because human safety data extend only to 8 weeks, periodic breaks rather than indefinite daily use help mitigate the unknown risks of chronic exposure. ## Therapeutic Protocol Theacrine is used as a stimulant/energy and focus supplement rather than a treatment, and protocols are drawn from supplement research and practitioner usage rather than formal clinical guidelines. * **Standard effective dose:** Most human studies and practitioner guidance use **100–300 mg per day**, with **~200 mg** being the most studied single acute dose for energy, mood, and focus. The branded TeaCrine form is the most researched. * **Competing approaches — alone vs. stacked with caffeine:** One common approach uses theacrine alone as a lower-jitter energy aid; another, supported by the strongest cognitive data, combines lower-dose caffeine (~100–150 mg) with theacrine (50–150 mg) to leverage caffeine-enhanced absorption and complementary effects. Neither is established as definitively superior; the combination has more supportive performance data, while theacrine-alone is favored by those seeking minimal cardiovascular impact. The branded combination products (e.g., TeaCrine, and stacks pairing it with caffeine and methylliberine/Dynamine) were popularized largely by supplement formulators and studied by research groups at the University of Memphis and the University of South Carolina. * **Best time of day:** Morning or early afternoon is generally preferred because of the long half-life; dosing within ~8 hours of bedtime has shown small, non-significant effects on sleep in dose-response work, but earlier use is more conservative. * **Half-life:** Theacrine's elimination half-life is approximately **16–22 hours** in humans — far longer than caffeine — supporting once-daily dosing. * **Single vs. split dosing:** Because of the long half-life, theacrine is typically taken as a **single daily dose**; splitting offers little advantage and risks late-day stimulation. * **Genetic considerations:** No validated pharmacogenetic guidance exists for theacrine; variants influencing general stimulant sensitivity (e.g., COMT, affecting dopamine clearance) may theoretically alter response but are not used to guide dosing. * **Sex-based differences:** Studies have included both sexes but are too small to support sex-specific dosing; the same general doses are used for men and women. * **Age-related considerations:** Protocols are derived from healthy young adults; conservative, lower starting doses are reasonable for older adults given altered clearance and higher baseline blood pressure, though direct data are lacking. * **Baseline biomarkers:** No specific biomarker is required before use; blood pressure is the most relevant baseline measure for those with cardiovascular risk. * **Pre-existing conditions:** Those with hypertension, anxiety, arrhythmia, or insomnia should use the lowest effective dose or avoid theacrine, as these conditions modify the risk-benefit balance. ## Discontinuation & Cycling * **Lifelong vs. short-term:** Theacrine is used as an as-needed or short-to-medium-term energy aid, not a lifelong therapy; there is no evidence-based rationale for indefinite daily use, and human safety data extend only to 8 weeks. * **Withdrawal effects:** No formal withdrawal syndrome has been documented. Because theacrine appears to cause little tolerance in animal models and the 8-week human study reported no habituation, abrupt discontinuation is not expected to produce caffeine-like withdrawal, though this has not been rigorously studied. * **Tapering:** Given the absence of a recognized withdrawal effect, tapering is generally unnecessary; users can typically stop without a structured taper. * **Cycling:** Some practitioners suggest periodic breaks (e.g., a few days off per week, or off-weeks) to preserve sensitivity and limit continuous exposure, though the low-tolerance profile means cycling is more a precaution than a proven necessity. Cycling is also reasonable given the lack of long-term safety data. * **Practical discontinuation note:** If theacrine is combined with caffeine, any caffeine-withdrawal symptoms (headache, fatigue) on stopping would stem from the caffeine component, not theacrine itself. ## Sourcing and Quality * **Branded vs. generic theacrine:** Most human research used the branded, nature-identical form TeaCrine; choosing this or other clearly labeled, standardized theacrine helps ensure the dose matches the evidence base. * **Third-party testing:** Because theacrine is sold as a dietary supplement with limited regulatory oversight, prefer products that carry independent third-party testing or certification (e.g., NSF, Informed Sport, USP) to verify identity, dose accuracy, and absence of contaminants. * **Label transparency and blends:** Theacrine is frequently buried in proprietary pre-workout blends where the exact theacrine dose is undisclosed; single-ingredient products or blends with fully disclosed amounts are preferable for controlling dose. * **Purity and form:** Look for products specifying theacrine content in milligrams per serving and, ideally, the branded or standardized source; avoid products that list only a proprietary blend total. * **Reputable suppliers:** Established nootropic and supplement vendors that publish certificates of analysis (e.g., specialist nootropic retailers offering standalone theacrine capsules or powder) are generally more reliable than unbranded marketplace listings. ## Practical Considerations * **Time to effect:** Subjective energy and focus effects typically begin within **1–2 hours** of an oral dose; the long half-life means effects can persist for many hours and accumulate with daily dosing. * **Common pitfalls:** Taking it too late in the day (risking subtle sleep effects), stacking it on top of high caffeine intake (raising stimulant load and theacrine exposure), using undisclosed-dose proprietary blends, and escalating to high mg/kg doses chasing performance benefits that the evidence does not support. * **Regulatory status:** In the United States, theacrine is marketed as a dietary supplement ingredient and is not an approved drug; it is not evaluated by the FDA for efficacy, and its use for energy or performance is effectively unregulated. Regulatory acceptance varies by country, and it is not universally permitted in sports-supplement markets. * **Cost and accessibility:** Theacrine is widely available online and is moderately priced; it is neither exceptionally expensive nor hard to obtain, though standalone (non-blend) products are less common than pre-workout formulations. ## Interaction with Foundational Habits * **Sleep:** Direct interaction. Theacrine's long half-life and adenosine-blocking activity can, in principle, interfere with sleep if taken late, though human dose-response data show only small, non-significant effects on sleep efficiency even at 400 mg. Practical consideration: dose in the morning or early afternoon, and avoid use within ~8 hours of bedtime to be safe. * **Nutrition:** Indirect interaction. No specific dietary requirement is established. Because caffeine enhances theacrine absorption, taking it with a caffeinated beverage will raise exposure; conversely, those wanting a milder effect can take it without caffeine. No clinically important nutrient depletion is documented. * **Exercise:** Direct but uncertain interaction. Theacrine is marketed as a pre-workout aid, but controlled trials show no reliable improvement in strength, sprint, agility, or endurance performance when used alone; any exercise benefit is mainly perceptual (energy, readiness) or appears in caffeine combinations. Practical consideration: it may improve workout "feel" more than measured output. * **Stress management:** Direct interaction with a cautionary note. While animal data suggest anti-stress and antidepressant-like effects, recent human data found high doses (up to 9 mg/kg) raised salivary cortisol, a stress hormone. Practical consideration: keep doses moderate, as high doses may nudge the stress axis in the wrong direction rather than supporting stress resilience. ## Monitoring Protocol & Defining Success For a low-risk supplement like theacrine, formal laboratory monitoring is not generally required; the most useful monitoring is self-assessment of subjective benefits and basic cardiovascular checks for those with risk factors. Baseline assessment is sensible mainly for individuals with cardiovascular concerns who choose to use higher doses. Baseline testing: Before starting, individuals with cardiovascular risk should record resting blood pressure and heart rate; broad lab panels are not warranted for typical use. Ongoing monitoring: For most users, no scheduled labs are needed. Those with elevated blood pressure or who use higher doses should re-check blood pressure at roughly 1–2 weeks after starting and periodically thereafter (e.g., every 1–3 months while using). | Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes | |-----------|--------------------------|-----------------|---------------| | Resting blood pressure | <120/80 mmHg | Detects dose-related increases | Higher doses (≥6 mg/kg) raised blood pressure; check at rest, seated, before dosing | | Resting heart rate | 50–70 bpm | Screens for stimulant effect | Generally unchanged at ~200 mg; measure before morning dose | | Salivary or morning cortisol | Within lab reference range | Flags stress-axis activation | Relevant mainly at high doses; conventional labs report a wide range, best measured in the morning | | Sleep quality (actigraphy or diary) | Stable vs. personal baseline | Detects subtle sleep disruption | Optional; most useful if dosing later in the day | Qualitative markers of success: * Sustained energy and reduced fatigue without a sharp "crash" * Improved focus, motivation, and mood during the day * Absence of jitteriness, palpitations, or anxiety * No disruption to sleep onset or quality * Stable or unchanged blood pressure and resting heart rate ## Emerging Research Theacrine research is active but small-scale, dominated by acute sports-nutrition and cognition studies; longevity-specific human research is essentially absent. * **Completed dose-response and hemodynamic trials:** A 2026 randomized crossover study testing high theacrine doses on hemodynamics, cognition, and stress ([NCT07376564](https://clinicaltrials.gov/study/NCT07376564), 19 participants, examining blood pressure, heart rate, cognitive performance, and salivary cortisol) found that high doses increased cortisol without improving energy or cognition — a direction-of-evidence that could weaken the case for high-dose use. * **Stem cell mobilization study:** A completed trial at the University of Memphis ([NCT06219161](https://clinicaltrials.gov/study/NCT06219161), 12 participants) examined whether an acute theacrine-based supplement changes circulating stem cell numbers, exploring a novel longevity-relevant mechanism; results could either open or close this line of inquiry. * **Fatigue and cognitive-health comparison trial:** A completed study comparing theacrine, *Alpinia galanga*, and caffeine formulations on fatigue and mental acuity ([NCT05170113](https://clinicaltrials.gov/study/NCT05170113), 79 participants) may clarify how theacrine compares head-to-head with other energy ingredients. * **Cognition without sleep disruption:** Dose-response work by Gardiner et al., 2024 ([PubMed](https://pubmed.ncbi.nlm.nih.gov/39562624/)) suggested 400 mg can improve some next-morning vigilance measures without significantly harming sleep — a promising direction that needs replication in larger, longer studies. * **Caffeine-combination cognition under stress:** A 2025 randomized trial by Lints et al., 2025 ([PubMed](https://pubmed.ncbi.nlm.nih.gov/40693646/)) found caffeine-plus-theacrine improved cognitive performance under fatigue beyond caffeine alone, strengthening the case for combination use while leaving theacrine-alone benefits unresolved. * **Future directions that could change understanding:** Key open questions include whether theacrine has any chronic (beyond 8 weeks) safety or benefit signal, whether its animal-level liver-protective, anti-inflammatory, and neuroprotective effects translate to humans, and whether high-dose cortisol and blood-pressure signals represent a meaningful downside. Larger, longer, theacrine-alone human trials with objective endpoints are needed to settle both the optimistic and skeptical interpretations. ## Conclusion Theacrine is a natural compound closely related to caffeine, found in a wild Chinese tea, and used mainly as an energy and focus supplement. Its appeal rests on a longer-lasting, smoother feel than caffeine, with early human studies showing that a moderate dose can increase felt energy, improve mood and concentration, and reduce fatigue without much change in heart rate or blood pressure. Animal research adds intriguing but unproven possibilities — liver protection, reduced inflammation, and brain-protective effects — that have not been tested in people. The overall evidence base is thin and mixed, and much of the early favorable human research was funded or run by companies that sell theacrine, a conflict of interest that warrants extra caution when weighing those positive findings. The most reliable findings are subjective: people often feel more energetic and focused, especially when theacrine is paired with a small amount of caffeine. Objective performance benefits in exercise have largely failed to appear, and newer studies using higher doses found raised blood pressure, a rise in a stress hormone, and a range of stimulant-type side effects, tempering the early enthusiasm. For someone focused on long-term health, theacrine looks reasonably safe at moderate doses over a couple of months, but its longevity benefits remain speculative and its long-term safety untested. The honest summary is a smoother short-term stimulant with an uncertain place in a longevity strategy. **[Top](#top) - [Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol)**